MAPT and Alzheimer disease: In addition to the plasma Aβ42/40 ratio, several phosphorylated forms of Tau protein in blood plasma, namely pTau181, pTau231 and pTau217, were discovered to represent highly attractive biomarkers for AD [23–25].